focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Double dip for EZ economy in Q4 and more downside risks

Thu, 29th Oct 2020 12:07

* European shares fall in choppy trade after sell-off

* Eyes on ECB policy meeting

* Results from Facebook, Amazon, Google, Apple due later
Welcome to the home for real-time coverage of markets brought to
you by Reuters reporters. You can share your thoughts with us at
markets.research@thomsonreuters.com

DOUBLE DIP IN Q4 AND MORE DOWNSIDE RISKS (1206 GMT)

Virus trajectories are the major issue for the euro zone
economy and now probably also for stocks as the correlation
between Covid and European equity is back to its highest levels.

Hopes that the virus will be less dangerous than last spring
are fading as hospitalisations and ICU (intensive care unit)
occupancy are starting to pick up (see charts below).

According to Morgan Stanley, more lockdowns might be on
their way in Europe.

“Belgium looks to have the health care system under most
strain,” while further “measures in Italy and the Netherlands
also look possible.”

Cases in Ireland, which imposed a similar partial lockdown a
week ago, “seem to be edging lower.”

Bottom line, MS projects a 0.1% fall in euro area GDP over
Q4 2020 and a weak Q1 2021, “with downside risks if the
restrictions persist or become more stringent.”

Morgan Stanley confirms its expectations of more easing from
the ECB at its December policy meeting.

A UBS analysis yesterday suggested that one month rolling
correlation between the Stoxx 600 and new Covid cases is back to
April levels while there was none from May to end-September.

(Stefano Rebaudo)

*****

MORE BAD NEWS FOR LUXURY (1020 GMT)

Nobody likes restrictive measures but luxury will probably
be one of the hardest hit industries after France said it would
go back to a nationwide lockdown.

“The impact of store closures in France, one of the biggest
luxury goods markets in the region, in the important Q4, and
looming risk of further closures across the continent is going
to result in negative earnings revisions for the companies in
our coverage,” a UBS research note says.

The new measures in France, which will last until Dec. 1,
will mean people have to stay in their homes except to buy
essential goods, seek medical attention, or use their daily
one-hour allocation of exercise.

(Stefano Rebaudo)

*****

EUROPE OPENS HIGHER AS TECH SHINES (0848 GMT)

European stocks manage to keep their head above water as of
now, after yesterday’s brutal selloff as focus turns to an ECB
policy meeting which might give some clues about fresh stimulus.

Tech stocks are among the best performers, despite a double
digit fall in Nokia shares, ahead of results in the
from Apple, Alphabet, Facebook and Twitter.

The Stoxx 600 index is up 0.3%, with real estate
sector leading gains up 1.1% and tech stocks up 1%. Insurers and
travel and leisure stocks are down about 0.6%.

Shares in Orange are up 5.1% after results, while
BT +7% after the company raises the lower end of its
earnings outlook for the year.

Royal Dutch Shell shares rise 3.8% after the
company said it will increase its third-quarter dividend by 4%
and reported stronger-than-expected profits.

(Stefano Rebaudo)

*****

ON THE RADAR: SHELL, AB INBEV, AIRBUS, NOKIA (0733 GMT)

European stocks are attempting to open slightly higher a day
after the biggest fall in months and hours ahead of an ECB
policy meeting.

Meanwhile senior sources in the British government expect
the vaccine, which Pfizer is co-developing with Germany's
BioNTech, could be ready to distribute before
Christmas, the Times reports. A verdict on this vaccine will be
available before the results are in on AstraZeneca Plc's
competing vaccine, it adds.

On the corporate front, a batch of good results is on its
way, with Nokia reporting third-quarter underlying
profit in line with market expectations.

Royal Dutch Shell will increase its third-quarter
dividend by 4% after stronger-than-expected profits in the
quarter.

Anheuser-Busch InBev reports a surprise increase in
beer sales in the third quarter, although profits dip and its
interim dividend payment is scrapped due to the COVID-19
pandemic.

Airbus expects to reach cash breakeven in the
fourth quarter, setting the first forward-looking target since
the start of the coronavirus crisis, after posting revenues of
11.2 billion euros versus analysts’ expectations of 11.4
billion.

Shares in Fresenius are up 2.3% in premarket trade
after the company’s third-quarter net income beats expectations.

Orange posts a 0.4% decline in its third-quarter
core operating profit, beating market expectations.

Telefonica expects a return to revenue growth in
2022 after a 785 million euro impairment charge in Argentina
dragged it to a net loss in the third quarter.

Volkswagen shares are up 1.8% in premarket trade
after the company returned to profitability in the third
quarter.

Roche shares are up 2.5% in premarket trade after
Chinese approval of Tecentriq.

Credit Suisse Group is seen down 1% after the bank
posts a 546 million Swiss francs in July-September, which is
compared with the 572 million franc median of 17 analyst
estimates compiled by the lender.

Standard Chartered booked a smaller-than-expected
40% slide in quarterly profit as the lender lowered its loan
loss expectations, also saying client demand was likely to
increase next year.

U.S. jeweller Tiffany & Co agreed with LVMH
to slightly lower the price of its acquisition by the
French luxury goods group, in a move set to end a legal dispute
between the two.

(Stefano Rebaudo)

*****

EUROPEAN STOCKS POISED FOR A REBOUND (0633 GMT)

European stock futures are in positive territory after
yesterday’s biggest fall in months on fears about the economic
impact of new restrictive measures across Europe.

Equities seem ready for a rebound ahead of an ECB policy
meeting scheduled for today which might give some clues about a
possible new round of economic stimulus.

German unemployment and inflation data, European confidence
surveys will also be closely watched, while uncertainty about
U.S. presidential elections and coronavirus worries continue to
keep investors on edge.

(Stefano Rebaudo)

*****

More News
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.